Roche has signed a Memorandum of Understanding (MoU) with VinCense, a digital health monitoring offering by MedIoTek Health Systems. Under the terms of the agreement, the two companies aim to implement 3 programmes in Madurai district of Tamil Nadu- (i) screening 100,000 individuals over the next two years for diabetes, hypertension, obesity etc. (ii) intervention for uncontrolled diabetes mellitus management (iii) intervention for tuberculosis - diabetes mellitus co-morbidity management. The partnership will use comprehensive integrated digital health solutions to drive early detection, intervention and care continuum in the state.

Roche and VinCense successfully conducted a pilot between December 2022 and September 2023 in collaboration with the Directorate of Public Health, Tamil Nadu, focusing on non-communicable disease (NCD) screening and management in the Madurai Corporation Urban Primary Health Centres (UPHCs).

The pilot phase saw screening of 67,370 individuals across the Madurai district out of which 16.6% people were identified to be at risk for diabetes and attached to the public healthcare system. Learnings from this pilot will bring efficiency and scalability to set new standards for accessible, inclusive, and technology-driven healthcare.